1JS vs GSK: Side-by-Side Comparison
Compare Shield Therapeutics plc (1JS) and GSK Plc (GSK) side by side: market cap EUR 72.73M vs USD 107.63B. Financials, growth and model signals on Bullrun.
| Metric | 1JS | GSK |
|---|---|---|
| Company | Shield Therapeutics plc | GSK Plc |
| Country / Exchange | United Kingdom · F | United Kingdom · NYSE |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers-General |
| Market cap | EUR 72.73M | USD 107.63B |
| P/E ratio | — | 14.0 |
| Dividend yield | — | 3.34% |
| Valuation model | — | 36.9% undervalued |
| Revenue (latest FY) | EUR 49.70M | — |
| Revenue growth YoY | +54.4% | — |
| Net income | EUR -17.66M | — |
| Gross margin | 46.4% | — |
| Diluted EPS | -0.02 | — |